PD-L1 Testing for Immune Checkpoint Inhibitors in Mesothelioma: For Want of Anything Better?

Lantuejoul, Sylvie; Le Stang, Nolwenn; Damiola, Francesca; Scherpereel, Arnaud; Galateau-Sallé, Francoise

Lantuejoul, Sylvie; Le Stang, Nolwenn; Damiola, Francesca; Scherpereel, Arnaud; Galateau-Sallé, Francoise.

Afiliação

Lantuejoul S; Department of Biopathology, National referent center MESOPATH-National Clinicobiologic Databasis MESOBANK, Cancer Center of Léon Bérard, Lyon, France; UGA/INSERM U1209/CNRS 5309-Institute for Advanced Biosciences-University Grenoble Alpes, Grenoble, France. Electronic address: sylvie.lantuejoul@lyon
Le Stang N; Department of Biopathology-Register MESONAT, Cancer Center of Léon Bérard, Lyon, France; INSERM UMR 1086, Cancers & Preventions, University Caen Basse-Normandie, Caen, France.
Damiola F; Department of Biopathology, National referent center MESOPATH-National Clinicobiologic Databasis MESOBANK, Cancer Center of Léon Bérard, Lyon, France.
Scherpereel A; University Lille, CHU Lille, MESOCLIN, Lille, France.
Galateau-Sallé F; Department of Biopathology, National referent center MESOPATH-Base National Clinicobiologic Databasis MESOBANK Register multicenter MESONAT-Sante public cancer center of Léon Bérard, Lyon, France.

J Thorac Oncol ; 12(5): 778-781, 2017 05.

Article em En | MEDLINE | ID: mdl-28434510

Assuntos

Neoplasias Pulmonares; Mesotelioma; Humanos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares / Mesotelioma Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google